Dr

Dr. Gregg Clopath | LinkedIn

https://www.linkedin.com/profile/preview?locale=en_US&tr...

%

$

Dr. Gregg Clopath

1st

Biotechnology

Current

CEO at andZyme Bioscience (USA), CEO at andZyme
Bioscience (Middle East and Africa), CEO at andZyme
Bioscience (Spain)

Previous

Max Zeller Soehne AG, Merz Pharma, Nestle

Education

Université de Lausanne

297

Send a message

connections

!

2

4

'

8

(

Ads You May Be Interested In

หลักสูตร MBA USC Marshall
เตรียมพร้อมเป็นผู้บริหารระดับสูง เรียน
1ปี L.A. หรือ Part-time ที่ Shanghai

CEO at andZyme Bioscience (Middle East & Africa)
India

&

Advanced

Contact Info

Background

›

Google AdWords™ India
Official Free Support from
Google™. Start Today and Save
Rs.2000!

›

Gx Market Intelligence
Make sure you know everything before investing in new market entry projects

›

People Also Viewed
Klaus Hammer
Manager bei Genioo Workforce
Solutions

"

Summary

Salvatore Volante
Managing Director at

Gregg Clopath is the CEO of andZyme Bioscience Inc and has several years of experience in the international pharmaceutical industry. With an emphasis on strategic sales management , marketing and business development , he is also an entrepreneur who mounted his own business "Aptnet" Canada - a company that specializes in ERP and CRM technology. This experience has enabled Dr Clopath to create Zyme, a technology that further develops pharmaceutical licensing.
Gregg Clopath has authored five books titled "The Chinese Pharmaceutical Industry, a prospective analysis", "The Strategic Guide to Pharmaceutical Licensing", "University Licensing & Spin-Outs",
"Artificial Intelligence an increasingly important role in Pharmaceutical Licensing" and "Knowledge
Management in theory and practice".

Riet Vermoesen verpleegkundige bij UZ Brussel

Maamar DLIOUAH
Construction Professional

Soline LACOUR
Pharmaceutical Industry

Specialties: Licensing, M&A and AI: 11 oncology, 1 RA, 1 MS products licensed and 81 partnerships structured with